Fudan University: Thyroid Neoplasms trials
The registry lists 15 Thyroid Neoplasms studies with Fudan University as lead sponsor. 10 are open to participants now and 0 have results posted.
Phase 2 9Phase 3 2No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid CancerRecruitingNCT07777536Phase 2
- Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical StudyEnrolling by invitationNCT07755423
- MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTCRecruitingNCT07235566Phase 2
- Anlotinib and Benmelstobart in DTCNot yet recruitingNCT07193186Phase 2
- Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid CancerRecruitingNCT06970353Phase 2
- Adjuvant Radiotherapy in High Risk Locally Advanced DTCRecruitingNCT06558981Phase 3
- Selective Neck Dissection Versus Modified Neck Dissection in PTCRecruitingNCT06554652Phase 3
- RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid CancerRecruitingNCT06530316
- RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid CancerRecruitingNCT06524167
- Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid CancerRecruitingNCT05989425Phase 2
- Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid CancerStatus unknownNCT04612894Phase 2
- Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II StudyStatus unknownNCT04524884Phase 2
- Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid CancerCompletedNCT04521348Phase 2
- Lateral Neck Lymph Node Mapping in Thyroid CancerStatus unknownNCT04312087Not applicable
- Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid CancerStatus unknownNCT04309136Phase 2